Heron Therapeutics
HRTX
HRTX
196 hedge funds and large institutions have $3.33B invested in Heron Therapeutics in 2018 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 66 increasing their positions, 54 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
22% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 54
3.57% less ownership
Funds ownership: 125.57% → 122% (-3.6%)
61% less call options, than puts
Call options by funds: $41.6M | Put options by funds: $107M
Holders
196
Holding in Top 10
11
Calls
$41.6M
Puts
$107M
Top Buyers
| 1 | +$115M | |
| 2 | +$101M | |
| 3 | +$67.4M | |
| 4 |
BlackRock
New York
|
+$40.1M |
| 5 |
BM
Bridger Management
New York
|
+$28M |
Top Sellers
| 1 | -$83.5M | |
| 2 | -$45M | |
| 3 | -$42.6M | |
| 4 |
BC
Broadfin Capital
New York
|
-$41.2M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$33.3M |